Table 2.
EGFR Mutants | exon19del | EGFR_L858R | Wildtype EGFR | ||||
---|---|---|---|---|---|---|---|
Inhibitor | Properties | Chain A | Chain B | Chain A | Chain B | Chain A | Chain B |
Erlotinib | Binding Energy of inhibitor | −46.61 | −36.29 | −63.30 | −56.41 | −62.06 | −40.37 |
Binding Energy of ATP | −35.92 | −32.26 | −38.51 | −37.26 | −38.94 | −56.57 | |
DFG motif and αC-helix orientation * | Out | In | In | In | In | In | |
Distance between Lys745 and Glu762 | 3.6 and 3.1 | 3.4 and 3.2 | 3.9 and 2.8 | 9.6 and 6.4 | 6.4 and 4.7 | 6.5 and 7.5 | |
Downward movement of P loop | No | Yes | Yes | No | No | Yes | |
CAPE | Binding Energy of inhibitor | −38.15 | − 58.83 | −45.43 | −49.22 | −65.68 | −63.23 |
Binding Energy of ATP | −37.61 | −34.63 | −26.92 | −23.62 | −58.39 | −30.15 | |
DFG motif and αC-helix orientation * | In | In | In | In | In | In | |
Distance between Lys745 and Glu762 | 3.6 and 3.5 | 3.4 and 3.7 | 3.9 and 3.1 | 9.6 and 6.5 | 6.4 and 3.9 | 6.5 and 10.1 | |
Downward movement of P loop | Yes | yes | Yes | Yes | No | Yes | |
Wi-A | Binding Energy of inhibitor | −49.35 | −46.23 | −22.52 | −44.50 | −49.50 | −48.78 |
Binding Energy of ATP | −45.06 | −30.59 | −56.43 | −62.40 | −35.78 | −35.78 | |
DFG motif and αC-helix orientation * | In | In | In | In | In | In | |
Distance between Lys745 and Glu762 | 3.6 and 3.4 | 3.4 and 3.2 | 3.9 and 3.1 | 9.6 and 6.4 | 6.4 and 3.5 | 6.5 and 6.4 | |
Downward movement of P loop | No | No | No | No | No | Yes | |
Wi-N | Binding Energy of inhibitor | −59.83 | −22.21 | −45.76 | −51.86 | −44.88 | −51.70 |
Binding Energy of ATP | −14.15 | −23.45 | −20.82 | −20.29 | −35.42 | −37.25 | |
DFG motif and αC-helix orientation * | In | In | In | In | In | In | |
Distance between Lys745 and Glu762 | 3.6 and 3.6 | 3.4 and 3.2 | 3.9 and 3.7 | 9.6 and 6.4 | 6.4 and 3.3 | 6.5 and 7.8 | |
Downward movement of P loop | Yes | Yes | Yes | Yes | No | No |
* ‘In’ refers to DFG and αC-helix inward conformation; ‘Out’ refers to DFG and αC-helix outward conformation.